Tonix Pharmaceuticals (NASDAQ: TNXP) , a biopharmaceutical company developing innovative vaccines, is advancing TNX-801, a live, minimally replicatin ...

Tonix Pharmaceuticals Holding Corp.’s TNXP share price has dipped by 19.78%, which has investors questioning if this is right ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...

After hours: March 19 at 7:59:43 PM EDT Loading Chart for TNXP ...

Blood tests can also be used to diagnose HAE. If all other causes of angioedema have been excluded, your healthcare provider may decide to check the level of a substance called C1 esterase inhibitor, ...

At close: March 17 at 4:00:00 PM EDT Loading Chart for PHAR ...

Tonix Pharmaceuticals (NASDAQ: TNXP) announced its fourth-quarter and full-year 2024 financial results, alongside key operational updates. The compan ...

Pharming Group (NASDAQ:PHAR – Get Free Report) had its price target hoisted by research analysts at Oppenheimer from $30.00 ...

Preoperative vaginal dysbiosis has been identified as an independent risk factor for the recurrence of endometrial polyps ...